• National reports
• Tendances
• Drugs, key data
• Drugs, international challenges
• Monographs
• Methodology
• Papers
• Memo/posters/maps

Memo

Memo designed to respond to specific requests from authorities.

• June 2017: "25x-NBOMe" type molecules - Available information on the diffusion of a class of NPS in France
  (lire la version originale en français)

• May 2017: Tobacco smoking and tobacco cessation in 2016
  (lire la version originale en français)

• March 2017: Cannabis regulations in the United States
  (lire la version originale en français)

• March 2017: Analysis of drugs in sewage: an approach to assess substance use, applied to a prison setting
  (lire la version originale en français)

• December 2016: Legislations on narcotics in Europe in 2016: common points and differences
  (lire la version originale en français)

• March 2016: Legislation relating to cannabis use and possession: definitions and overview of the situation in Europe
  (lire la version originale en français)

• February 2016: Tobacco smoking and tobacco cessation in 2015
  (lire la version originale en français)

• September 2015: The social cost of drugs in France
  (lire la version originale en français)

• July 2014: Morphine sulphate consumption by French drug users: recent trends (2012-2013)
  (lire la version originale en français)

• June 2014: Use of ketamine in France: recent trends (2012-2013)
  (lire la version originale en français)

• February 2014: Results of the ETINCEL - OFDT electronic cigarette survey: Prevalence, purchase and use behaviours, reasons for using electronic cigarettes
  (lire la version originale en français)

Presentations, posters, maps

Presentations and posters made for conferences and other international events; maps.

• Presentation made for the 38th Salis/AMHL Conference (Denver, 4–7 May 2016): New cannabis regulations implemented in Americas: Perceptions and repercussions ine Europe (France, United Kingdom, Italy, Spain, Switzerland) (pps)
  
  
• Mapping of the legislation relating to the use and possession of cannabis within the EU-28 (March 2016) (jpg)
  
  
• Posters made for the Lisbon Addictions conference (23–25 September 2015): What is new on ecstasy in France? Shapes, rates and user perceptions - An exploratory research on benzodiazepines’ drug users - HBSC and ESPAD in France: a marriage of convenience, but not only! - Estimating the number of PDU with mortality data when drug-related deaths are under-reported (pdf)
  
  
• Mapping of the national cannabis laws on use or possession of small amounts for personal use in the European Union (1 August 2012) (pdf)
  
  Although cannabis is a classified narcotic drug placed under control by the United Nations and by all EU Member States, the measures adopted to control it at national level vary considerably.
  This summary map provides an overview of the legal approaches towards cannabis use or possession of small quantities of cannabis for personal use in the European Union (27) (on 1 August 2012).
  It maps the possible sanctions set out in the different countries of the EU for cannabis-related minor offences, such as use or possession of small quantities for personal use.
  It also shows which countries distinguish cannabis from other substances (giving cannabis-related offences a special legal treatment) and which countries gave legal status to the use of medicinal cannabis.
  
  
• Posters made for the EMCDDA 15 years conference organised in Lisbon, 6-8 May 2009 about opioid substitution treatments in France and the SINTES monitoring system (pdf)
  
  
• Poster made for the 38th World Congress of the International Institute of Sociology,. Budapest, 27-28 June 2008: Gender differences in drug use in France: a matter of social status? (pdf)